Pharmaceutical containment and delivery systems manufacturer with global manufacturing footprint
SCHOTT Pharma manufactures drug containment and delivery systems—glass/polymer syringes, vials, cartridges, ampoules—for injectable medications. The company operates 16 manufacturing sites across Europe, the Americas, and Asia, serving over 1,800 customers including the top 30 pharma manufacturers. Active hiring across manufacturing, engineering, and quality roles signals ongoing capacity expansion and process digitalization, with notable focus on GMP data integrity, cleanroom requalification, and reducing scrap—operational levers typical of capital-intensive, heavily regulated pharmaceutical manufacturing.
Notable leadership hires: Production Team Lead
SCHOTT Pharma is a publicly listed pharmaceutical manufacturer headquartered in Mainz, Germany, with around 4,700 employees across more than 60 nations. The company designs and manufactures drug containment and delivery systems, serving the injectable pharmaceuticals market. Its portfolio spans prefillable glass and polymer syringes, cartridges, vials, and ampoules, with over 1,000 in-house patents and a dedicated R&D center in Switzerland. The company generated EUR 957 million in revenue in fiscal year 2024 and operates manufacturing hubs in all major pharmaceutical regions. SCHOTT Pharma is committed to achieving climate neutrality by 2030 and is part of SCHOTT AG, owned by the Carl Zeiss Foundation.
Prefillable glass and polymer syringes, cartridges, vials, and ampoules for injectable drugs. The company serves over 1,800 customers, including the top 30 pharma manufacturers, with over 1,000 proprietary patents.
Headquartered in Mainz, Germany, with approximately 4,700 employees across 16 manufacturing sites in Europe, North and South America, and Asia, representing over 60 nations.
Other companies in the same industry, closest in size